Fluorescence lifetime imaging ophthalmoscopy in type 2 diabetic patients who have no signs of diabetic retinopathy
Fluorescence lifetime imaging ophthalmoscopy in type 2 diabetic patients who have no signs of diabetic retinopathy
复制标题
DOI:
10.1117/1.jbo.20.6.061106
复制
发表时间:
2015-06-01
影响因子:
3.5
通讯作者:
Dawczynski, Jens
中科院分区:
文献类型:
--
作者:
Schweitzer, Dietrich;Deutsch, Lydia;Dawczynski, Jens
The time-resolved autofluorescence of the eye is used for the detection of metabolic alteration in diabetic patients who have no signs of diabetic retinopathy. One eye from 37 phakic and 11 pseudophakic patients with type 2 diabetes, and one eye from 25 phakic and 23 pseudophakic healthy subjects were included in the study. After a three-exponential fit of the decay of autofluorescence, histograms of lifetimes tau(i), amplitudes alpha(i), and relative contributions Q(i) were statistically compared between corresponding groups in two spectral channels (490 < ch1 < 560 nm, 560 < ch2 < 700 nm). The change in single fluorophores was estimated by applying the Holm-Bonferroni method and by calculating differences in the sum histograms of lifetimes. Median and mean of the histograms of tau(2), tau(3), and alpha(3) in ch1 show the greatest differences between phakic diabetic patients and age-matched controls (p < 0.000004). The lack of pixels with a tau(2) of similar to 360 ps, the increased number of pixels with tau(2) > 450 ps, and the shift of tau(3) from similar to 3000 to 3700 ps in ch1 of diabetic patients when compared with healthy subjects indicate an increased production of free flavin adenine dinucleotide, accumulation of advanced glycation end products (AGE), and, probably, a change from free to protein-bound reduced nicotinamide adenine dinucleotide at the fundus. AGE also accumulated in the crystalline lens. (C) The Authors. Published by SPIE under a Creative Commons Attribution 3.0 Unported License.